secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2025-04-15T23:59:59+00:00
Accession:  0001213900-25-032119
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aditxt secures call option to purchase $25M Evofem convertible notes for $13M
-----------------------------------------------------------------------------

- Aditxt granted call option to acquire Evofem convertible notes (aggregate $25M principal) and purchase rights from Adjuvant funds for $13M.
- Option exercisable after Future Pak Note fully repaid, until June 30, 2025; exercise triggers $13M payment.
- If Aditxt does not provide $1.5M capital to Evofem by April 30, 2025, Adjuvant may transfer securities without consent.
- Evofem consents to assignment of notes and waives opinion of counsel requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390025032119/0001213900-25-032119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390025032119/ea0238436-8k_aditxt.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-032119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer